Gotham Asset Management LLC Has $44.51 Million Holdings in Masimo Corporation $MASI

Gotham Asset Management LLC boosted its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 165.2% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 342,194 shares of the medical equipment provider’s stock after acquiring an additional 213,168 shares during the quarter. Gotham Asset Management LLC’s holdings in Masimo were worth $44,506,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of MASI. Global Retirement Partners LLC acquired a new position in Masimo during the fourth quarter worth approximately $27,000. Aster Capital Management DIFC Ltd acquired a new position in Masimo during the fourth quarter worth approximately $28,000. Los Angeles Capital Management LLC bought a new stake in shares of Masimo during the fourth quarter worth approximately $31,000. Rothschild Investment LLC grew its position in shares of Masimo by 12,950.0% in the fourth quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after purchasing an additional 259 shares during the last quarter. Finally, Torren Management LLC acquired a new position in shares of Masimo in the fourth quarter valued at approximately $35,000. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Stock Performance

Shares of MASI stock opened at $179.95 on Thursday. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The stock has a market cap of $9.42 billion, a P/E ratio of -17.07, a price-to-earnings-growth ratio of 1.82 and a beta of 1.11. The stock has a 50 day simple moving average of $178.78 and a 200 day simple moving average of $161.40. Masimo Corporation has a 1 year low of $125.94 and a 1 year high of $179.99.

Analyst Ratings Changes

Several equities analysts have recently commented on MASI shares. Wolfe Research downgraded Masimo from a “strong-buy” rating to a “hold” rating in a research report on Thursday, February 19th. Raymond James Financial downgraded Masimo from an “outperform” rating to a “market perform” rating in a research report on Friday, March 27th. Wells Fargo & Company raised Masimo to a “hold” rating in a research report on Wednesday, March 18th. Weiss Ratings raised Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Wednesday, May 6th. Finally, BTIG Research downgraded Masimo from a “buy” rating to a “neutral” rating in a research report on Wednesday, February 18th. Nine equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, Masimo has a consensus rating of “Hold” and a consensus target price of $180.40.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.